Found: 130
Select item for more details and to access through your institution.
Disseminated Mycobacterium avium Complex Infection Following CD3/CD20 Bispecific Antibody Therapy in a Patient With Follicular Lymphoma.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
SARS-CoV-2 Polymerase Chain Reaction Cycle Threshold Trends in Patients Who Are Immunocompromised and Implications for Isolation Precautions.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae367
- By:
- Publication type:
- Article
Immune Control in Repeated Babesia microti Infection in a Patient With B-Cell Deficiency.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 1, p. 1, doi. 10.1093/ofid/ofad568
- By:
- Publication type:
- Article
SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 7, p. 1, doi. 10.1093/ofid/ofad349
- By:
- Publication type:
- Article
Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 11, p. 1, doi. 10.1093/ofid/ofac565
- By:
- Publication type:
- Article
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac417
- By:
- Publication type:
- Article
US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 12, p. 1, doi. 10.1093/ofid/ofab563
- By:
- Publication type:
- Article
Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 12, p. 1, doi. 10.1093/ofid/ofab504
- By:
- Publication type:
- Article
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 10, p. 1, doi. 10.1093/ofid/ofab441
- By:
- Publication type:
- Article
Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab153
- By:
- Publication type:
- Article
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 1, p. 1, doi. 10.1093/ofid/ofaa606
- By:
- Publication type:
- Article
87. Heart and Lung Transplants From HCV-Viremic Donors to Uninfected Patients: Longer-Term Follow-Up.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S5, doi. 10.1093/ofid/ofz359.011
- By:
- Publication type:
- Article
Screening and Monitoring for Infectious Complications When Immunosuppressive Agents Are Studied in the Treatment of Autoimmune Disorders.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2015, v. 4, n. 3, p. 198, doi. 10.1093/jpids/piu055
- By:
- Publication type:
- Article
Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies.
- Published in:
- Emerging Infectious Diseases, 2022, v. 28, n. 9, p. 1859, doi. 10.3201/eid2809.220729
- By:
- Publication type:
- Article
An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centre.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Quinolones and False-Positive Urine Screening for Opiates by Immunoassay Technology.
- Published in:
- JAMA: Journal of the American Medical Association, 2001, v. 286, n. 24, p. 3115, doi. 10.1001/jama.286.24.3115
- By:
- Publication type:
- Article
Is the BCG Vaccine an Answer to Future Pandemic Preparedness?
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 201, doi. 10.3390/vaccines10020201
- By:
- Publication type:
- Article
Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22446-z
- By:
- Publication type:
- Article
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22446-z
- By:
- Publication type:
- Article
High-Dose Recombinant Canarypox Vaccine Expressing HIV-1 Protein, in Seronegative Human Subjects.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 7, p. 1249
- By:
- Publication type:
- Article
Enterovirus 71 Infections and Neurologic Disease—United States, 1977–1991.
- Published in:
- Journal of Infectious Diseases, 1994, v. 169, n. 4, p. 905, doi. 10.1093/infdis/169.4.905
- By:
- Publication type:
- Article
Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 788, doi. 10.1111/bjh.15627
- By:
- Publication type:
- Article
Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial.
- Published in:
- PLoS Medicine, 2024, v. 21, n. 6, p. 1, doi. 10.1371/journal.pmed.1004329
- By:
- Publication type:
- Article
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-44090-5
- By:
- Publication type:
- Article
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38892-w
- By:
- Publication type:
- Article
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39292-w
- By:
- Publication type:
- Article
Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0143165
- By:
- Publication type:
- Article
Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029231
- By:
- Publication type:
- Article
Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024517
- By:
- Publication type:
- Article
A Phase IIA Randomized Clinical Trial of a Multiclade HIV- 1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204).
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0021225
- By:
- Publication type:
- Article
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.
- Published in:
- 2015
- By:
- Publication type:
- journal article
First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002).
- Published in:
- Journal of Infectious Diseases, 2014, v. 210, n. 7, p. 1052, doi. 10.1093/infdis/jiu217
- By:
- Publication type:
- Article
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 5, p. 818, doi. 10.1093/infdis/jit236
- By:
- Publication type:
- Article
Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 12, p. 1888, doi. 10.1093/infdis/jit105
- By:
- Publication type:
- Article
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001).
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 2, p. 240, doi. 10.1093/infdis/jis670
- By:
- Publication type:
- Article
Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001).
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 2, p. 248, doi. 10.1093/infdis/jis671
- By:
- Publication type:
- Article
Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects HIV-1 Vaccine Immunogenicity in HIV-Seronegative Subjects.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 10, p. 1541, doi. 10.1093/infdis/jir615
- By:
- Publication type:
- Article
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 5, p. 610
- By:
- Publication type:
- Article
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. Suppl 2, p. 610
- By:
- Publication type:
- Article
Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 9, p. 1361, doi. 10.1086/651561
- By:
- Publication type:
- Article
Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 9, p. 1353, doi. 10.1086/651560
- By:
- Publication type:
- Article
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
- Published in:
- American Journal of Health-System Pharmacy, 2013, v. 70, n. 17, p. 1518, doi. 10.2146/ajhp120599
- By:
- Publication type:
- Article
Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. e2215984, doi. 10.1001/jamanetworkopen.2022.15984
- By:
- Publication type:
- Article
Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. 1, doi. 10.1001/jamanetworkopen.2022.15984
- By:
- Publication type:
- Article
Fungal Infections of the CNS: Treatment Strategies for the Immunocompromised Patient.
- Published in:
- CNS Drugs, 2007, v. 21, n. 4, p. 293, doi. 10.2165/00023210-200721040-00004
- By:
- Publication type:
- Article
Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System: A Population-Based Cohort Study.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 1, p. 77, doi. 10.7326/M22-2141
- By:
- Publication type:
- Article